Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
LEGN
Home
/
LEGN

NASDAQ
$22.77
$22.77

Overview

Price performance
Low
$21.67
High
$23.71
After hours. Last updated: Nov 4, 2026, 9:00 PM UTC
$
22.77
1.29 (6.01%)
Average, 50 days
$19.55
$22.13
Open
$22.33
Previous close
$21.48
52-week high
$37.50
Jun 3, 2026 (6 months ago)
52-week low
$16.24
Feb 4, 2026 (10 months ago)
40.21%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
4.21B
Volume
3 155 573
Total Return (3M)
19.03%
Total Return (1Y)
-28.95%
17.07
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
legendbiotech.com
About
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.

Frequently asked questions

LEGN · Legend Biotech Corporation

01What is Legend Biotech Corporation stock price today?

The current price of LEGN is $22.77 — it has increased by 6.01% since the previous close. Data as of Nov 4, 2026.

02Is Legend Biotech Corporation stock price growing?

LEGN is up 2.94% over the past week, up 22.62% over the past month and down 28.95% over the past year. The price is above its 200-day moving average of $22.13.

03What is LEGN stock forecast?

Analysts' average 12-month price target for LEGN is $61.00, which implies 167.90% upside from the current price. Individual estimates range from $40.00 to $78.00.

04What do analysts say about LEGN stock?

Of the 13 analysts covering Legend Biotech Corporation, 5 rate it a strong buy, 3 rate it a buy and 5 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

05What is Legend Biotech Corporation market cap?

Legend Biotech Corporation has a market capitalization of $4.21B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

06What were Legend Biotech Corporation earnings last quarter?

In its most recent quarterly report, Legend Biotech Corporation posted earnings of $0.09 per share against an estimate of $0.12, missing expectations by 25.00%. Upcoming reports are listed in the earnings calendar.

07What is Legend Biotech Corporation revenue for the last quarter?

Legend Biotech Corporation reported revenue of $387.5M in its most recent quarter, which has increased by 51.93% compared with the same quarter a year earlier. Analysts had expected $355.96M.

08Does Legend Biotech Corporation pay dividends?

Legend Biotech Corporation has not paid any dividends over the past year.

09Who are Legend Biotech Corporation competitors?

Companies most comparable to Legend Biotech Corporation include Allogene Therapeutics, Inc., Autolus Therapeutics plc, Century Therapeutics, Inc., Lyell Immunopharma, Inc. and Fate Therapeutics, Inc.

10How volatile is LEGN stock?

In the latest trading session LEGN moved between $21.67 and $23.71, a range of 8.96% of its current price.

11Should I invest in Legend Biotech Corporation stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Legend Biotech Corporation shows a strong buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Legend Biotech Corporation is sell. Technical ratings are indicators, not investment advice.

12What are LEGN stock 52-week high and low?

Over the past 52 weeks LEGN has traded between $16.24 and $37.50. The current price is 39.28% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.